Viewing Study NCT06520709



Ignite Creation Date: 2024-10-26 @ 3:36 PM
Last Modification Date: 2024-10-26 @ 3:36 PM
Study NCT ID: NCT06520709
Status: COMPLETED
Last Update Posted: None
First Post: 2024-07-20

Brief Title: Kinesiophobia in Postmenopausal Osteoporosis
Sponsor: None
Organization: None

Study Overview

Official Title: Kinesiophobia and Associated Factors in Postmenopausal Osteoporosis A Controlled Study
Status: COMPLETED
Status Verified Date: 2024-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study aims to evaluate kinesiophobia levels in postmenopausal women with osteoporosis compared to a healthy control group and to explore the relationships between kinesiophobia and various psychosocial factors including quality of life fear of falling and symptoms of depression and anxiety
Detailed Description: This cross-sectional controlled study aims to explore kinesiophobia levels in postmenopausal women with osteoporosis compared to healthy age-matched controls Postmenopausal osteoporosis is a systemic condition characterized by reduced bone mineral density which increases fracture risk and can significantly affect individuals physical activity and overall quality of life Kinesiophobia or the irrational fear of movement due to perceived injury risk can further exacerbate this issue by restricting physical activity which is vital for maintaining bone health The study will involve 60 postmenopausal women diagnosed with osteoporosis and 60 healthy age-matched women without osteoporosis or osteopenia Participants will be recruited from the outpatient clinics of İstanbul Physical Therapy and Rehabilitation Training and Research Hospital between January 21 2024 and February 21 2024 The study will assess kinesiophobia using the Turkish version of the Tampa Scale for Kinesiophobia TSK quality of life with the Quality of Life Questionnaire of the European Foundation for Osteoporosis QUALEFFO-41 and symptoms of depression and anxiety using the Hospital Anxiety and Depression Scale HADS Additionally the Tinetti Falls Efficacy Scale TFES will evaluate fear of falling and bone mineral density will be measured using dual-energy X-ray absorptiometry DXA

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None